{"log_id": 242047050966137103, "direction": 0, "words_result_num": 34, "words_result": [{"probability": {"variance": 0.010664, "average": 0.952493, "min": 0.497665}, "location": {"width": 730, "top": 228, "height": 43, "left": 263}, "words": "a.CLcR:依据 E Cockcroft- Gault公式并根据实际体重而估计的肌酐清除率"}, {"probability": {"variance": 0.006719, "average": 0.9752, "min": 0.535421}, "location": {"width": 714, "top": 273, "height": 41, "left": 298}, "words": "CAPD:连续不卧床腹膜透析; AUCO-:外推至无穷大的浓度-时间曲线下"}, {"probability": {"variance": 0.011204, "average": 0.966883, "min": 0.424416}, "location": {"width": 716, "top": 318, "height": 41, "left": 298}, "words": "面积;AUC在24小时给药间隔期间达稳态时所计算的浓度一时间曲线下"}, {"probability": {"variance": 1e-06, "average": 0.99907, "min": 0.997276}, "location": {"width": 86, "top": 374, "height": 25, "left": 298}, "words": "面积;C"}, {"probability": {"variance": 0.001728, "average": 0.978513, "min": 0.858207}, "location": {"width": 273, "top": 367, "height": 34, "left": 435}, "words": "稳态波谷浓度;NA:不适用"}, {"probability": {"variance": 4.6e-05, "average": 0.996688, "min": 0.966641}, "location": {"width": 747, "top": 407, "height": 40, "left": 269}, "words": "b.患有复杂性皮肤及软组织感染的患者及健康受试者单次给药后所获得的"}, {"probability": {"variance": 0.001274, "average": 0.962615, "min": 0.926917}, "location": {"width": 49, "top": 462, "height": 26, "left": 271}, "words": "参数"}, {"probability": {"variance": 1e-06, "average": 0.99921, "min": 0.996316}, "location": {"width": 549, "top": 497, "height": 38, "left": 299}, "words": "从患有金黄色葡萄球菌菌血症患者中获得的稳态时参数"}, {"probability": {"variance": 0.005582, "average": 0.978695, "min": 0.568172}, "location": {"width": 758, "top": 539, "height": 42, "left": 261}, "words": "由于肾脏排泄是药物的主要消除途径,因此有必要对严重肾损害(CLc30"}, {"probability": {"variance": 0.000117, "average": 0.995942, "min": 0.954735}, "location": {"width": 290, "top": 596, "height": 28, "left": 225}, "words": "ml/min)的患者调整本品剂量"}, {"probability": {"variance": 1.4e-05, "average": 0.998125, "min": 0.989159}, "location": {"width": 161, "top": 643, "height": 27, "left": 274}, "words": "肝功能损伤患者"}, {"probability": {"variance": 4e-06, "average": 0.998476, "min": 0.992477}, "location": {"width": 744, "top": 677, "height": 38, "left": 274}, "words": "在10名中度肝损伤的受试者中,对达托霉素的药代动力学进行了评价,并将"}, {"probability": {"variance": 0.000561, "average": 0.993276, "min": 0.871684}, "location": {"width": 792, "top": 721, "height": 39, "left": 226}, "words": "其与性别、年龄和体重相匹配的健康志愿者(N=9)的药代动力学进行比较。在中"}, {"probability": {"variance": 5.6e-05, "average": 0.997183, "min": 0.961632}, "location": {"width": 793, "top": 764, "height": 42, "left": 228}, "words": "度肝功能不全的受试者中,达托霉素的药代动力学没有变化。因而,当给予轻度"}, {"probability": {"variance": 0.000159, "average": 0.993168, "min": 0.936082}, "location": {"width": 790, "top": 809, "height": 41, "left": 230}, "words": "至中度肝功能不全患者( Child- Pugh B级)本品时,无需调整剂量。尚未对达托霉"}, {"probability": {"variance": 0.001262, "average": 0.988264, "min": 0.818905}, "location": {"width": 686, "top": 855, "height": 40, "left": 229}, "words": "素在严重肝功能损伤患者( Child- Pugh C级)中的药代动力学进行评价"}, {"probability": {"variance": 2.1e-05, "average": 0.995208, "min": 0.990665}, "location": {"width": 48, "top": 911, "height": 26, "left": 275}, "words": "性别"}, {"probability": {"variance": 5e-06, "average": 0.999058, "min": 0.987213}, "location": {"width": 746, "top": 944, "height": 38, "left": 276}, "words": "研究表明,在达托霉素的药代动力学方面,未观察到具有临床意义的与性别"}, {"probability": {"variance": 2.1e-05, "average": 0.997339, "min": 0.980704}, "location": {"width": 573, "top": 990, "height": 37, "left": 230}, "words": "相关的差异。当给予本品时,无需针对性别进行剂量调整"}, {"probability": {"variance": 0.059569, "average": 0.756624, "min": 0.3831}, "location": {"width": 131, "top": 960, "height": 65, "left": 964}, "words": "园信海"}, {"probability": {"variance": 0, "average": 0.999434, "min": 0.998834}, "location": {"width": 96, "top": 1043, "height": 28, "left": 266}, "words": "老年患者"}, {"probability": {"variance": 0.005331, "average": 0.981444, "min": 0.536992}, "location": {"width": 754, "top": 1077, "height": 39, "left": 270}, "words": "在12名健康老年受试者(≥75岁)和11名健康青年对照受试者(18~30岁)中对"}, {"probability": {"variance": 0.006103, "average": 0.645625, "min": 0.567503}, "location": {"width": 39, "top": 1062, "height": 33, "left": 1118}, "words": "口时"}, {"probability": {"variance": 0.001488, "average": 0.987358, "min": 0.828701}, "location": {"width": 791, "top": 1123, "height": 37, "left": 232}, "words": "达托霉素的药代动力学进行评价。单次30分钟静脉给予4mg/kg本品后,与青年"}, {"probability": {"variance": 0, "average": 0.842045, "min": 0.842045}, "location": {"width": 86, "top": 1113, "height": 68, "left": 1047}, "words": "但"}, {"probability": {"variance": 8.6e-05, "average": 0.996229, "min": 0.959172}, "location": {"width": 789, "top": 1167, "height": 38, "left": 233}, "words": "健康受试者相比,达托霉素在老年受试者中的平均总体清除率约降低35%,平均"}, {"probability": {"variance": 0.008416, "average": 0.967085, "min": 0.647665}, "location": {"width": 561, "top": 1213, "height": 37, "left": 240}, "words": "UC约增加了58%。两组间在C上无差异(见老年用药)"}, {"probability": {"variance": 0, "average": 0.999814, "min": 0.999666}, "location": {"width": 70, "top": 1267, "height": 26, "left": 280}, "words": "肥胖症"}, {"probability": {"variance": 0.006513, "average": 0.968605, "min": 0.638666}, "location": {"width": 747, "top": 1301, "height": 38, "left": 281}, "words": "在6名中度肥胖(体重指数[BMI]为25~39.9kg/m2)和6名极度肥胖(BMI≥40"}, {"probability": {"variance": 0.003005, "average": 0.988698, "min": 0.658365}, "location": {"width": 797, "top": 1346, "height": 38, "left": 232}, "words": "kg/m2)的受试者及年龄、性别和肾功能相匹配的对照受试者中,对达托霉素的药"}, {"probability": {"variance": 0.000326, "average": 0.993667, "min": 0.895494}, "location": {"width": 793, "top": 1391, "height": 37, "left": 235}, "words": "代动力学进行了评价。根据总体重单次30分钟静脉给予4mg/kg的本品后,中度"}, {"probability": {"variance": 0.000335, "average": 0.995033, "min": 0.892015}, "location": {"width": 786, "top": 1435, "height": 37, "left": 235}, "words": "肥胖和极度肥胖受试者中,达托霉素的总血浆清除率(按总体重进行了标准化"}, {"probability": {"variance": 0.002225, "average": 0.989287, "min": 0.703955}, "location": {"width": 794, "top": 1479, "height": 39, "left": 235}, "words": "分别比非肥胖对照受试者中的参数值低约15%和23%。中度肥胖和极度肥胖受试者"}, {"probability": {"variance": 2.8e-05, "average": 0.997166, "min": 0.96892}, "location": {"width": 795, "top": 1525, "height": 39, "left": 236}, "words": "中达托霉素的AUC分别约比非肥胖对照受试者中的高30%和31%。该差异的原因"}], "language": 3}